Holdings over time
(Since February 1, 2022)
| Instrument | Avg. Exposure | Current Exposure | Time Holding | Last Closed |
|---|---|---|---|---|
 ImmunoGen Inc (IMGN) | 4.03% | 0% | 68.98% | 2/14/2024 |
 Eli Lilly (LLY) | 3.99% | 2.66% | 96.68% | - |
 Bridgebio (BBIO) | 3.85% | 3.58% | 67.07% | - |
 Vertex (VRTX) | 3.65% | 3.05% | 96.68% | - |
 Merck (MRK) | 3.4% | 2.32% | 96.68% | - |
 CRISPR Therapeutics (CRSP) | 3.4% | 2.93% | 96.68% | - |
 Regeneron (REGN) | 3.35% | 2.07% | 96.68% | - |
 Johnson & Johnson (JNJ) | 3.26% | 3.53% | 96.68% | - |
 Gilead Sciences (GILD) | 3.16% | 3.73% | 96.68% | - |
 AbbVie (ABBV) | 3.14% | 2.76% | 96.68% | - |
 Amgen (AMGN) | 3.13% | 2.62% | 96.68% | - |
 Bristol-Myers Squibb (BMY) | 3.07% | 3.91% | 96.68% | - |
 Exact Sciences (EXAS) | 2.94% | 3.8% | 96.68% | - |
 Illumina (ILMN) | 2.91% | 4.23% | 96.48% | - |
 Pfizer (PFE) | 2.89% | 2.49% | 96.68% | - |
 Guardant Health (GH) | 2.75% | 3.47% | 96.68% | - |
 Iovance (IOVA) | 2.36% | 3.03% | 67.07% | - |
 Argenx (ARGX) | 2.21% | 4.03% | 67.07% | - |
 Revolution Medicines (RVMD) | 2.2% | 4.63% | 67.07% | - |
 Blueprint Medicines (BPMC) | 2.2% | 2.82% | 67.07% | - |
 Exelixis (EXEL) | 2.15% | 4.67% | 60.83% | - |
 Mirati Therapeutics Inc (MRTX) | 2.04% | 0% | 67.57% | 1/31/2024 |
 Syndax (SNDX) | 2.01% | 2.98% | 67.07% | - |
 BeiGene (BGNE) | 1.78% | 0% | 64.65% | 1/2/2024 |
 Fate Therapeutics (FATE) | 1.61% | 0% | 64.65% | 1/2/2024 |
 Seagen Inc (SGEN) | 1.5% | 0% | 33.53% | 12/18/2023 |
 Arcellx (ACLX) | 1.3% | 5.48% | 32.02% | - |
 Crinetics (CRNX) | 1.29% | 4.27% | 32.02% | - |
 Legend Biotech (LEGN) | 1.23% | 0% | 35.05% | 1/2/2024 |
 Incyte (INCY) | 1.21% | 0% | 29.61% | 1/12/2023 |
 BioNTech SE (BNTX) | 1.13% | 0% | 29.61% | 1/12/2023 |
 2Seventy Bio (TSVT) | 1.12% | 0% | 29.61% | 1/12/2023 |
 SpringWorks Therapeutics (SWTX) | 1.1% | 3.12% | 32.02% | - |
 AstraZeneca (AZN) | 1.04% | 2.5% | 32.02% | - |
 Option Care Health (OPCH) | 1.01% | 2.46% | 32.02% | - |
 Agenus (AGEN) | 1% | 0% | 29.61% | 1/12/2023 |
 LabCorp (LH) | 0.98% | 0% | 29.61% | 1/12/2023 |
 Rocket (RCKT) | 0.94% | 1.96% | 32.02% | - |
 GlaxoSmithKline (GSK) | 0.92% | 0% | 29.61% | 1/12/2023 |
 MannKind (MNKD) | 0.91% | 0% | 35.05% | 1/2/2024 |
 Arvinas (ARVN) | 0.91% | 2.59% | 32.02% | - |
 BD (BDX) | 0.91% | 2.7% | 32.02% | - |
 TG Therapeutics (TGTX) | 0.89% | 5.24% | 25.78% | - |
 Zai Lab (ZLAB) | 0.8% | 0% | 35.05% | 1/2/2024 |
 Sorrento (SRNE) | 0.8% | 0% | 29.61% | 1/12/2023 |
 Celldex (CLDX) | 0.76% | 0% | 35.05% | 1/2/2024 |
 Inovio (INO) | 0.76% | 0% | 29.61% | 1/12/2023 |
 Clovis Oncology Inc (CLVSQ) | 0.67% | 0% | 27.59% | 12/22/2022 |
 Surface Oncology Inc (SURF) | 0.5% | 0% | 27.59% | 12/22/2022 |
 Invitae Corp (NVTAQ) | 0.37% | 0% | 29.61% | 1/12/2023 |
 Curis (CRIS) | 0.34% | 0% | 27.59% | 12/22/2022 |
Exposure over time
Exposure by Sector
Exposure by Country
Portfolio Time Machine
Portfolio date
01
01
2024
| Instrument | Invested | Value |
|---|---|---|
| ImmunoGen Inc (IMGN) | 3.68% | 15.23% |
| Bridgebio (BBIO) | 3.06% | 12.1% |
| Blueprint Medicines (BPMC) | 3.06% | 4.67% |
| Eli Lilly (LLY) | 2.12% | 3.92% |
| Exelixis (EXEL) | 3.06% | 3.47% |
| Mirati Therapeutics Inc (MRTX) | 5.07% | 3.4% |
| Vertex (VRTX) | 2.42% | 3.36% |
| Iovance (IOVA) | 3.06% | 3.18% |
| CRISPR Therapeutics (CRSP) | 3.68% | 3.15% |
| Regeneron (REGN) | 2.69% | 2.99% |
| Exact Sciences (EXAS) | 3.68% | 2.77% |
| Legend Biotech (LEGN) | 3.06% | 2.76% |
| Amgen (AMGN) | 2.56% | 2.56% |
| Revolution Medicines (RVMD) | 3.06% | 2.55% |
| AbbVie (ABBV) | 2.95% | 2.43% |
| Merck (MRK) | 2.11% | 2.34% |
| Argenx (ARGX) | 3.06% | 2.3% |
| Gilead Sciences (GILD) | 2.15% | 2.27% |
| Johnson & Johnson (JNJ) | 2.88% | 2.16% |
| Guardant Health (GH) | 5.07% | 2.12% |
| Syndax (SNDX) | 3.06% | 2.01% |
| Celldex (CLDX) | 3.06% | 2.01% |
| MannKind (MNKD) | 3.06% | 1.77% |
| BeiGene (BGNE) | 2.63% | 1.73% |
| Bristol-Myers Squibb (BMY) | 2.93% | 1.72% |
| Illumina (ILMN) | 4.56% | 1.7% |
| Zai Lab (ZLAB) | 3.06% | 1.61% |
| Fate Therapeutics (FATE) | 6.15% | 1.6% |
| Pfizer (PFE) | 3.03% | 1.47% |